Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 54
Filtrer
1.
Angew Chem Int Ed Engl ; 61(31): e202206900, 2022 08 01.
Article de Anglais | MEDLINE | ID: mdl-35652453

RÉSUMÉ

The modification of surfaces with multiple ligands allows the formation of platforms for the study of multivalency in diverse processes. Herein we use this approach for the implementation of a photosensitizer (PS)-nanocarrier system that binds efficiently to siglec-10, a member of the CD33 family of siglecs (sialic acid (SA)-binding immunoglobulin-like lectins). In particular, a zinc phthalocyanine derivative bearing three SA moieties (PcSA) has been incorporated in the membrane of small unilamellar vesicles (SUVs), retaining its photophysical properties upon insertion into the SUV's membrane. The interaction of these biohybrid systems with human siglec-10-displaying supported lipid bilayers (SLBs) has shown the occurrence of weakly multivalent, superselective interactions between vesicle and SLB. The SLB therefore acts as an excellent cell membrane mimic, while the binding with PS-loaded SUVs shows the potential for targeting siglec-expressing cells with photosensitizing nanocarriers.


Sujet(s)
Liposomes , Lectines liant l'acide sialique apparentées aux immunoglobulines , Membrane cellulaire/métabolisme , Humains , Ligands , Lectines liant l'acide sialique apparentées aux immunoglobulines/métabolisme
2.
ACS Cent Sci ; 6(12): 2311-2318, 2020 Dec 23.
Article de Anglais | MEDLINE | ID: mdl-33376792

RÉSUMÉ

Understanding how emerging influenza viruses recognize host cells is critical in evaluating their zoonotic potential, pathogenicity, and transmissibility between humans. The surface of the influenza virus is covered with hemagglutinin (HA) proteins that can form multiple interactions with sialic acid-terminated glycans on the host cell surface. This multivalent binding affects the selectivity of the virus in ways that cannot be predicted from the individual receptor-ligand interactions alone. Here, we show that the intrinsic structural and energetic differences between the interactions of avian- or human-type receptors with influenza HA translate from individual site affinity and orientation through receptor length and density on the surface into virus avidity and specificity. We introduce a method to measure virus avidity using receptor density gradients. We found that influenza viruses attached stably to a surface at receptor densities that correspond to a minimum number of approximately 8 HA-glycan interactions, but more interactions were required if the receptors were short and human-type. Thus, the avidity and specificity of influenza viruses for a host cell depend not on the sialic acid linkage alone but on a combination of linkage and the length and density of receptors on the cell surface. Our findings suggest that threshold receptor densities play a key role in virus tropism, which is a predicting factor for both their virulence and zoonotic potential.

3.
Langmuir ; 36(42): 12745-12754, 2020 Oct 27.
Article de Anglais | MEDLINE | ID: mdl-33074008

RÉSUMÉ

In this paper, we obtain maps of the spatial tunnel barrier variations in self-assembled monolayers of organosulfurs on Au(111). Maps down to the sub-nanometer scale are obtained by combining topographic scanning tunneling microscopy images with dI/dz spectroscopy. The square root of the tunnel barrier height is directly proportional to the local work function and the dI/dz signal. We use ratios of the tunnel barriers to study the work function contrast in various decanethiol phases: the lying-down striped ß phase, the dense standing-up φ phase, and the oxidized decanesulfonate λ phase. We compare the induced work function variations too: the work function contrast induced by a lying-down striped phase in comparison to the modulation induced by the standing-up φ phase, as well as the oxidized λ phase. By performing these comparisons, we can account for the similarities and differences in the effects of the mechanisms acting on the surface and extract valuable insights into molecular binding to the substrate. The pillow effect, governing the lowering of the work function due to lying-down molecular tails in the striped low density phases, seems to have quite a similar contribution as the surface dipole effect emerging in the dense standing-up decanethiol phases. The dI/dz spectroscopy map of the nonoxidized ß phase compared to the map of the oxidized λ phase indicates that the strong binding of molecules to the substrate is no longer present in the latter.

4.
Crit Rev Food Sci Nutr ; 60(14): 2446-2459, 2020.
Article de Anglais | MEDLINE | ID: mdl-31366215

RÉSUMÉ

Irvingia gabonensis, also known as 'bush mango', is a multipurpose fruit tree, native to tropical Africa. It is a priority indigenous fruit tree in western and central Africa since its wood is used for making utensils and fruits are mostly used as food and medicine. The objective of this work is to provide an updated review of the available knowledge about physicochemical characteristics of I. gabonensis fruit in order to evaluate its potential use in the food industry. The fruit mesocarp contains various phytochemicals and ascorbic acid concentration higher than some vitamin C rich fruits, then it is consumed fresh or dried, used to produce juice and wine, or as a flavourant. I. gabonensis fruit kernel is rich in oil (63%-69% crude fat), mainly composed of myristic and lauric acids. Its triacylglycerol composition and, resultantly, melting curve and polymorphism indicate an aptitude for diverse applications, as it is solid at room temperature. Forty-one phenolic compounds were identified in the seeds and derived extracts and supplements, being ellagic acid and its derivates the most present. This review enhances our knowledge about nutritional content and health benefits of I. gabonensis whole fruit, especially its pulp and seed, evidencing the need for safer and more efficient production of value-added products.


Sujet(s)
Cellulose/composition chimique , Industrie alimentaire , Fruit/composition chimique , Afrique , Humains
5.
Rev. Fac. Odontol. (B.Aires) ; 33(75): 7-13, jul.-dic. 2018. ilus
Article de Espagnol | LILACS | ID: biblio-999353

RÉSUMÉ

Los traumatismos dentoalveolares que afectan a escolares pueden involucrar a los tejidos blandos y/o duros de las piezas primarias y permanentes jóvenes. Las causas por las que se producen son múltiples e incluyen caídas, accidentes en el hogar, actividad deportiva en el colegio o el club, accidentes de tránsito. El objetivo de este trabajo es presentar la resolución y el seguimiento a dos años de dos situaciones clínicas de traumatismos dentoalveolares en pacientes escolares que concurrieron a la Universidad de Buenos Aires, Facultad de Odontología, Odontología Integral Niños (AU)


Dentoalveolar trauma in schoolchildren can involve soft and/or hard tissues of deciduous and young permanent teeth. It has multiple causes, including falls, home accidents, sports accidents at school or at a club, and car accidents. The aim of the present work was to show treatmentand two-year clinical follow up of dentoalveolar trauma in schoolchildren seen at the Universidad de Buenos Aires, Facultad de Odontología, Odontología Integral Niños (AU)


Sujet(s)
Humains , Mâle , Enfant , Fractures dentaires , Extrusion dentaire , Traumatismes dentaires , Argentine , École dentaire , Études de suivi , Soins dentaires pour enfants , Coiffage pulpaire , Restaurations dentaires permanentes , Traitement d'urgence , Ferula , Ciment ionomère au verre
6.
Food Res Int ; 92: 40-47, 2017 02.
Article de Anglais | MEDLINE | ID: mdl-28290296

RÉSUMÉ

The purpose of the present study is to compare the effects of four different breads (one commercial par-baked wheat bread, three sourdough breads prepared with commercial wheat flour, organic wheat flour, organic einkorn flour) in 16 healthy subjects. The primary outcome of this randomized cross-over trial was evaluating intra-individual changes in glycemic areas-under-the-curve (AUCs) after 50g carbohydrate portions of each bread; secondary outcomes were changes in insulin, fatty free acids (FFA), triglyceride, acylated ghrelin and satiety AUCs. Blood samples and satiety ratings were collected every 30-min for 2-h after the consumption of each bread. The einkorn flour showed the lowest amylase activity, the commercial flour the highest; commercial bread had the highest carbohydrate content and the lowest dietary fiber content. Glucose AUCs were significantly lower after the consumption of sourdough breads made with organic (12,754±1433mg/dL×h) and einkorn flour (12,216±1210mg/dL×h), with respect to the commercial bread (13,849±2193mg/dL×h). Insulin AUCs decreased after the consumption of all sourdough breads when compared to commercial bread. FFA and triglyceride AUCs did not differ by kind of breads. Median ghrelin AUC was significantly lower and satiety higher after the einkorn bread (3710pg/mL×h; 3225±2414, respectively) than after commercial bread consumption (4140pg/mL×h; 1706±1766, respectively), but not with other sourdough breads. In conclusion, the use of sourdough may improve the nutritional features of breads; einkorn bread induced the least disturbance in carbohydrate homeostasis and the greater satiety. If confirmed by further research, these results might have implications in the approach towards chronic dysmetabolic diseases.


Sujet(s)
Glycémie/métabolisme , Pain , Acide gras libre/sang , Ghréline/sang , Insuline/sang , Satiété , Triglycéride/sang , Adulte , Études croisées , Régime alimentaire , Hydrates de carbone alimentaires/analyse , Matières grasses alimentaires/analyse , Fibre alimentaire , Protéines alimentaires/analyse , Méthode en double aveugle , Femelle , Farine , Humains , Mâle , Adulte d'âge moyen , Triticum/composition chimique , Tour de taille , Jeune adulte
7.
BJOG ; 122(1): 80-91, 2015 Jan.
Article de Anglais | MEDLINE | ID: mdl-25209926

RÉSUMÉ

OBJECTIVE: To evaluate the effectiveness of 200 mg of daily vaginal natural progesterone to prevent preterm birth in women with preterm labour. DESIGN: Multicentre, randomised, double-blind, placebo-controlled trial. SETTING: Twenty-nine centres in Switzerland and Argentina. POPULATION: A total of 385 women with preterm labour (24(0/7) to 33(6/7) weeks of gestation) treated with acute tocolysis. METHODS: Participants were randomly allocated to either 200 mg daily of self-administered vaginal progesterone or placebo within 48 hours of starting acute tocolysis. MAIN OUTCOME MEASURES: Primary outcome was delivery before 37 weeks of gestation. Secondary outcomes were delivery before 32 and 34 weeks, adverse effects, duration of tocolysis, re-admissions for preterm labour, length of hospital stay, and neonatal morbidity and mortality. The study was ended prematurely based on results of the intermediate analysis. RESULTS: Preterm birth occurred in 42.5% of women in the progesterone group versus 35.5% in the placebo group (relative risk [RR] 1.2; 95% confidence interval [95% CI] 0.93-1.5). Delivery at <32 and <34 weeks did not differ between the two groups (12.9 versus 9.7%; [RR 1.3; 95% CI 0.7-2.5] and 19.7 versus 12.9% [RR 1.5; 95% CI 0.9-2.4], respectively). The duration of tocolysis, hospitalisation, and recurrence of preterm labour were comparable between groups. Neonatal morbidity occurred in 44 (22.8%) cases on progesterone versus 35 (18.8%) cases on placebo (RR: 1.2; 95% CI 0.82-1.8), whereas there were 4 (2%) neonatal deaths in each study group. CONCLUSION: There is no evidence that the daily administration of 200 mg vaginal progesterone decreases preterm birth or improves neonatal outcome in women with preterm labour.


Sujet(s)
Poids de naissance , Travail obstétrical prématuré/traitement médicamenteux , Naissance prématurée/prévention et contrôle , Progestérone/usage thérapeutique , Progestines/usage thérapeutique , Administration par voie vaginale , Adulte , Score d'Apgar , Méthode en double aveugle , Femelle , Humains , Indométacine/usage thérapeutique , Nourrisson , Mortalité infantile , Nouveau-né , Unités de soins intensifs néonatals/statistiques et données numériques , Grossesse , Deuxième trimestre de grossesse , Troisième trimestre de grossesse , Récepteurs à l'ocytocine/antagonistes et inhibiteurs , Tocolytiques/usage thérapeutique , Jeune adulte
8.
Ciudad Autónoma de Buenos Aires; Ministerio de Salud de la Nación. Dirección de Investigación en Salud; 2014. 1 p.
Non conventionel de Espagnol | ARGMSAL, BINACIS | ID: biblio-1510301

RÉSUMÉ

INTRODUCCIÓN Existe una gran variación en la práctica de sedación paliativa (SP) para controlar síntomas refractarios en el final de vida. OBJETIVOS Explorar diferentes aspectos de la SP en una Unidad de Cuidados Paliativos (UCP) terciaria. MÉTODOS Se realizó un estudio retrospectivo comparativo sobre todos los pacientes internados en la UCP del Hospital Tornú entre 2011 y 2014. Se identificaron aquellos que habían recibido SP; se recogieron datos demográficos, clínicos, indicaciones de SP, fármacos y sobrevida. RESULTADOS De 319 pacientes internados, 41% requirieron SP durante los 4 años del estudio, con una prevalencia anual promedio de 25% y tendencia descendente. No se encontraron diferencias en las características demográficas, pronósticas y de confort entre los pacientes con y sin SP. Dentro de los pacientes con SP, un 86% ingresó con ECOG (Eastern Cooperative Oncology Group) 4. El 97% tuvo enfermedad oncológica (cáncer de pulmón: 51%). La principal causa de internación fue disnea, y el tiempo de sobrevida fue de 13±18 días. Las indicaciones principales para SP fueron delirium (66%) y disnea (29%) refractarios. En 91% de los casos se utilizó midazolam (34-68 mg/d) y en 48%, la combinación de dos o más fármacos (principalmente midazolam + levomepromazina). La modalidad de SP inicial fue superficial con evolución a profunda continua y duración de 3,5±2 días. Los principales opioides intrasedación fueron fentanilo y morfina (dosis equivalente de morfina oral promedio 57,1). Previamente a la SP se utilizó haloperidol y levomepromazina para control de delirium, y lorazepam y clonazepam para controlar ansiedad, insomnio y síntomas no relacionados a SP. Se obtuvo acuerdo con el paciente y/o familia para iniciar SP en 97% de los casos. DISCUSIÓN La SP tuvo una prevalencia acorde a la condición pronóstica y refractariedad de síntomas de los pacientes atendidos en la UCP. Las principales indicaciones fueron disnea y delirium, y el fármaco de elección fue midazolam. La SP se logró con acuerdo casi total de pacientes y/o familiares.


Sujet(s)
Soins palliatifs , Survie
9.
Brain Res ; 1471: 1-12, 2012 Aug 30.
Article de Anglais | MEDLINE | ID: mdl-22759906

RÉSUMÉ

Noise exposure is known to affect auditory structures in living organisms. However, it should not be ignored that many of the effects of noise are extra-auditory. Previous findings of our laboratory demonstrated that noise was able to induce behavioral alterations that are mainly related to the cerebellum (CE) and the hippocampus (HC). Therefore, the aim of this work was to reveal new data about the vulnerability of developing rat HC to moderate noise levels through the assessment of potential histological changes and hippocampal-related behavioral alterations. Male Wistar rats were exposed to noise (95-97 dB SPL, 2h daily) either for 1 day (acute noise exposure, ANE) or between postnatal days 15 and 30 (sub-acute noise exposure, SANE). Hippocampal histological evaluation as well as short (ST) and long term (LT) habituation and recognition memory assessments were performed. Results showed a mild disruption in the different hippocampal regions after ANE and SANE schemes, along with significant behavioral abnormalities. These data suggest that exposure of developing rats to noise levels of moderate intensity is able to trigger changes in the HC, an extra-auditory structure of the Central Nervous System (CNS), that could underlie the observed behavioral effects.


Sujet(s)
Symptômes comportementaux/étiologie , Symptômes comportementaux/anatomopathologie , Hippocampe/anatomopathologie , Bruit/effets indésirables , Facteurs âges , Analyse de variance , Animaux , Animaux nouveau-nés , Comportement animal/physiologie , Numération cellulaire , Comportement d'exploration , Femelle , Hippocampe/croissance et développement , Mâle , Apprentissage du labyrinthe/physiologie , Performance psychomotrice/physiologie , Rats , Rat Wistar , , Facteurs temps
10.
Int J Food Microbiol ; 143(1-2): 71-5, 2010 Sep 30.
Article de Anglais | MEDLINE | ID: mdl-20705353

RÉSUMÉ

The diversity, dynamics and activity of Castelmagno PDO cheese microbiota were studied in three batches produced in a floor valley farm, in the Grana Valley (northwest Italy), during the wintertime. Samples of milk, curd and cheese (core and subsurface) at different ripening time were submitted to both culture-dependent and -independent analysis. In particular, DNA and RNA directly extracted from the matrices were studied by PCR-Denaturing gradient gel electrophoresis (DGGE) and reverse transcription (RT)-PCR-DGGE. Culture-dependent methods highlighted the initial dominance of a thermophilic streptococcal population with the species Streptococcus thermophilus and S. agalactiae. Then, mesophilic lactococci occurred among isolates during manufacturing, with Lactococcus lactis which was also well represented in the first month of Castelmagno PDO ripening. At this point and throughout the ripening, lactobacilli prevailed in cheese samples, represented from Lactobacillus plantarum and Lb. casei. Culture-independent analysis underlined the undoubted role of L. lactis, actively involved in both Castelmagno PDO manufacturing and ripening. Despite Lb. helveticus was never isolated on selective media, a DGGE band referred to this microorganism was detected, at RNA level, in samples from ripened cheeses. On the other hand, Lb. plantarum was widely isolated from the plates, among lactobacilli, but never detected by direct analysis. Due to the importance of microbiota in the sensory richness and properties of traditional cheeses, new information have been added, in this work, on microbial diversity of Castelmagno PDO cheese.


Sujet(s)
Fromage/microbiologie , Manipulation des aliments/méthodes , Microbiologie alimentaire , Lactobacillus/isolement et purification , Lactococcus/isolement et purification , Streptococcus/isolement et purification , Biodiversité , ADN bactérien/analyse , Italie , Lactobacillus/génétique , Lactococcus/génétique , Métagénome , ARN bactérien/analyse , Streptococcus/génétique
11.
Transplant Proc ; 42(4): 1162-5, 2010 May.
Article de Anglais | MEDLINE | ID: mdl-20534250

RÉSUMÉ

INTRODUCTION: Vaginal administration seems to be the best route to achieve steady and precise doses of contraceptive hormones, resulting in stable serum concentrations and low exposure. The aim of this study was to evaluate the contraceptive efficacy, cycle control, tolerability and acceptability of a contraceptive vaginal ring (NuvaRing) in renal and liver transplant recipients. MATERIAL AND METHODS: Renal or liver transplant recipients, asking for contraception, were enrolled into the study. The duration of treatment was 12 cycles, with each vaginal ring releasing an average of 120 mg etonogestrel and 15 mg ethinylestradiol daily. Study visits were scheduled at screening, in the first week following cycles 3, 6, and 12 (172 cycles). RESULTS: Among 17 females included into the study: were 9 renal (mean age, 30 +/- 7.2 years) and 8 liver transplant recipients (mean age, 32.6 +/- 6.6 years). At the onset of therapy all patients showed at least 6 months of stable graft function with no signs of allograft rejection. The mean posttransplant follow-up was 4 +/- 3.6 and 5.3 +/- 2.1 years for women with renal and hepatic transplantations respectively (P = NS). The immunosuppressive therapy was not changed for any patient. We demonstrated good cycle control: 162 cycles did not exhibit any bleeding; 7 cycles, only spotting episodes, whereas 2 cycles had 1 bleeding episode during the ring period. The estrogen-related adverse events (nausea and breast tenderness) were reported in 2 patients. One patient experienced significant bleeding related to thrombocytopenia. DISCUSSION: Nuvaring, in our preliminary findings, may be considered to be an highly effective contraceptive method for female transplant recipients that additionally regulate menstrual bleeding and seems to positively influence well-being. Vaginal administration may diminish the chance of drug interactions and therefore be safer for patients.


Sujet(s)
Dispositifs contraceptifs féminins/statistiques et données numériques , Transplantation rénale/physiologie , Transplantation hépatique/physiologie , Adulte , Alanine transaminase/sang , Aspartate aminotransferases/sang , Pression sanguine , Contraceptifs féminins/analyse , Dispositifs contraceptifs féminins/effets indésirables , Désogestrel/analyse , Femelle , Études de suivi , Rythme cardiaque , Humains , Cycle menstruel , Grossesse , Issue de la grossesse , Sécurité
13.
Transplant Proc ; 40(6): 1877-80, 2008.
Article de Anglais | MEDLINE | ID: mdl-18675077

RÉSUMÉ

Progress in diagnosis and treatment has led to an increased number of transplantation patients who consequently have immunological depression and emergence of tumors. The incidence of cervical neoplasia, according to previous studies, is 11%; this tumor is the only one that can be investigated by screening before and after a graft. Our purpose was to evaluate whether transplanted patients showed an increased incidence of genital human papilloma virus (HPV) infection and whether this infection produced greater progression of disease in cases of low-risk HPV infections. Our study involved 151 transplant patients who underwent Papanicolaou (Pap) and HPV tests. Patients listed for grafts underwent Pap and HPV tests 6 months before and 6 months after transplantation. All patients had negative Pap tests before their grafts. After their grafts 16 patients (10.59%) had negative Pap tests, but positive viral typing. Eleven patients (7.28%) showed positive Pap tests, 6 of whom had low-grade squamous intraepithelial lesion (SIL) and 5 patients high-grade SIL. The final HPV infection incidence (15.23%) was consistent with the literature. The incidence of lower female genital tract intraepithelial lesions (7.28%) was higher than the healthy population or analogous studies (4.5%-8.5%). We showed a constant association between high-risk HPV infection and gynecologic intraepithelial neoplasia, whereas there was no association between low-risk broods HPV infection and neoplasia. In conclusion, screening should start at almost 6 months before grafting to avoid an irreversible situation that is difficult to treat.


Sujet(s)
Transplantation rénale/effets indésirables , Infections à papillomavirus/épidémiologie , Complications postopératoires/classification , Dysplasie du col utérin/épidémiologie , Tumeurs du col de l'utérus/épidémiologie , Adulte , Sujet âgé , Femelle , Humains , Immunosuppresseurs/effets indésirables , Incidence , Transplantation rénale/immunologie , Adulte d'âge moyen , Test de Papanicolaou , Papillomaviridae/isolement et purification , Tumeurs du col de l'utérus/anatomopathologie , Frottis vaginaux , Dysplasie du col utérin/anatomopathologie
14.
Int J Clin Pharmacol Ther ; 45(6): 307-18, 2007 Jun.
Article de Anglais | MEDLINE | ID: mdl-17595888

RÉSUMÉ

OBJECTIVE: Application-site disorders are well-known adverse events (AEs) associated with subcutaneous (s.c.) injection. With high-dose, high-frequency interferon (IFN)-beta1a (Rebif) these AEs are generally mild but may lead to the discontinuation of some patients. The objective of this study was to compare the safety, tolerability, and the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of two new formulations of Rebif (Rebif New Formulation: RNF1 and RNF2) with the current formulation (hereafter referred to as R) and placebo. METHODS: In this double-blind, placebo-controlled, parallel-group, Phase I study, healthy volunteers of both sexes were randomized 1:1:1:1 to receive a single 0.5 ml s.c. dose of RNF1, RNF2, R or placebo (normal saline). The three active treatments contained 44 microg IFN-beta1a. During the 24-hour post-dose period, safety and tolerability assessments were conducted and blood samples were taken at regular intervals for PK and PD analyses. Pain intensity on injection was measured using the short-form McGill questionnaire and a 100 mm visual analogue scale (VAS). Further safety assessments were performed and blood samples taken at 24-hour intervals until Day 7 post-dose, with a final post-study visit 10- 14 days after dosing. RESULTS: A total of 48 subjects (22 men, 26 women) were recruited and allocated equally to each treatment (12 subjects per group). AEs were reported by 10 subjects in each active treatment group and by 3 subjects in the placebo group. All AEs were consistent with the known safety profile of R. The number of treatment-emergent AEs was lower in the RNF2 group than the RNF 1 or R groups (21, 31 and 33 events, respectively). Redness at the injection site was mostly mild and occurred in fewer subjects in the RNF2 group (n = 3) than the RNF 1 or R groups (n = 7 and n = 4, respectively). Injection site pain was reported by 1 subject in the RNF2 group, compared with 4, 6 and 3 subjects, respectively, in the RNF1, R and placebo groups. The worst pain intensity, as measured by VAS, was lower in the RNF2 and RNFI groups than either the R or placebo groups. There was considerable intersubject variability in the PK and PD profiles of the three formulations of IFN-beta1a. Nevertheless, the PK and PD characteristics of RNF2 were similar to those of R. CONCLUSIONS: The results from this study suggest that RNF2 may offer improved tolerability compared with the current formulation of R, but retains comparable pharmacokinetic and pharmacodynamic characteristics.


Sujet(s)
Interféron gamma/pharmacologie , Interféron gamma/pharmacocinétique , Adolescent , Adulte , Aire sous la courbe , Chimie pharmaceutique , Méthode en double aveugle , Femelle , Période , Humains , Concentration en ions d'hydrogène , Injections sous-cutanées , Interféron gamma/effets indésirables , Mâle , Adulte d'âge moyen , Néoptérine/sang , Douleur/induit chimiquement , Douleur/épidémiologie , Mesure de la douleur/effets des médicaments et des substances chimiques , Protéines recombinantes , Enquêtes et questionnaires , Résultat thérapeutique , bêta-2-Microglobuline/sang
15.
Genet. mol. res. (Online) ; 4(2): 143-151, 30 jun. 2005. tab, ilus
Article de Anglais | LILACS | ID: lil-445297

RÉSUMÉ

We studied chromosomal abnormalities in arrested embryos produced by assisted reproductive technology with fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) in order to determine the best technique for evaluating chromosomal aneusomies to be implemented in different situations. We examined individual blastomeres from arrested embryos by FISH and arrested whole embryos by CGH. All of the 10 FISH-analyzed embryos gave results, while only 7 of the 30 embryos analyzed by CGH were usable. Fifteen of the 17 embryos were chromosomally abnormal. CGH provided more accurate data for arrested embryos; however, FISH is the technique of choice for screening in preimplantation genetic diagnosis, because the results can be obtained within a day, while the embryos are still in culture.


Sujet(s)
Humains , Femelle , Grossesse , Hybridation fluorescente in situ , Caryotypage/méthodes , Diagnostic préimplantatoire/méthodes , Génomique , Maladies chromosomiques/diagnostic , Maladies chromosomiques/embryologie , Maladies chromosomiques/génétique , Techniques de reproduction assistée
16.
Palliat Med ; 18(3): 177-83, 2004 Apr.
Article de Anglais | MEDLINE | ID: mdl-15198130

RÉSUMÉ

Breakthrough pain (BKP) is a transitory flare of pain that occurs on a background of relatively well controlled baseline pain. Previous surveys have found that BKP is highly prevalent among patients with cancer pain and predicts more severe pain, pain-related distress and functional impairment, and relatively poor quality of life. An international group of investigators assembled by a task force of the International Association for the Study of Pain (IASP) evaluated the prevalence and characteristics of BKP as part of a prospective, cross-sectional survey of cancer pain. Fifty-eight clinicians in 24 countries evaluated a total of 1095 patients with cancer pain using patient-rated items from the Brief Pain Inventory (BPI) and observer-rated measures. The observer-rated information included demographic and tumor-related data, the occurrence of BKP, and responses on checklists of pain syndromes and pathophysiologies. The clinicians reported BKP in 64.8% of patients. Physicians from English-speaking countries were significantly more likely to report BKP than other physicians. BKP was associated with higher pain scores and functional interference on the BPI. Multivariate analysis showed an independent association of BKP with the presence of more than one pain, a vertebral pain syndrome, pain due to plexopathy, and English-speaking country. These data confirm the high prevalence of BKP, its association with more severe pain and functional impairment, and its relationship to specific cancer pain syndromes. Further studies are needed to characterize subtypes of BKP. The uneven distribution of BKP reporting across pain specialists from different countries suggests that more standardized methods for diagnosing BKP are needed.


Sujet(s)
Tumeurs , Douleur/prévention et contrôle , Analyse de variance , Femelle , Humains , Mâle , Adulte d'âge moyen , Douleur/classification , Douleur/épidémiologie , Mesure de la douleur , Prévalence , Syndrome
17.
Growth Horm IGF Res ; 14(3): 226-34, 2004 Jun.
Article de Anglais | MEDLINE | ID: mdl-15125884

RÉSUMÉ

The aim of this study was to assess the in vivo efficacy of monoPEGylated GRF(1-29)NH(2) having one PEG(5000) chains attached to either lysine 12 or 21 as compared to the GRF(1-29)NH(2) in rats and pigs. This analogue termed GRF-1PEG(5000) was tested after a single intravenous administration in rats and after a single intravenous or subcutaneous injection in pigs. After 1 h administration, GH concentrations returned to values close to controls in the group of rats injected with GRF(1-29)NH(2). In animals injected with the same dose of GRF-1PEG(5000), the AUC values corresponding to the whole period 0.5-48 h and particularly to the 0.5-8 h period were higher than in the placebo or in the GRF(1-29)NH(2) groups. Interestingly, two additional peaks were observed at about 6 and 8 h following administration. An increase in the response of the endogenous GH peaks was also observed in pigs administered GRF-1PEG(5000) by intravenous route. When GRF-1PEG(5000) was administered subcutaneously to pigs, a significant increase, as compared to placebo and GRF(1-29)NH(2,) in both GH and IGF-I levels was observed. This new analogue might find therapeutic application in paediatric growth hormone deficiency or in aging.


Sujet(s)
Hormone de libération de l'hormone de croissance/analogues et dérivés , Polyéthylène glycols/composition chimique , Sermoréline/analogues et dérivés , Sermoréline/pharmacologie , Animaux , Hormone de croissance/sang , Hormone de croissance/métabolisme , Hormone de libération de l'hormone de croissance/sang , Hormone de libération de l'hormone de croissance/métabolisme , Humains , Injections veineuses , Injections sous-cutanées , Facteur de croissance IGF-I/analyse , Facteur de croissance IGF-I/métabolisme , Mâle , Rats , Rat Sprague-Dawley , Sermoréline/administration et posologie , Suidae
18.
J Sex Marital Ther ; 29 Suppl 1: 1-10, 2003.
Article de Anglais | MEDLINE | ID: mdl-12735085

RÉSUMÉ

There are limited hemodynamic data in women with arousal or orgasmic disorders and even fewer normative control hemodynamic data in women without sexual dysfunction. In addition, there is limited experience with topical vasoactive agents (used to maximize genital smooth muscle relaxation) applied to the external genitalia during hemodynamic evaluations. The aim of this study was to report duplex Doppler ultrasound clitoral cavernosal arterial changes before and after topical PGE-1 (Alprostadil) administration in control women and in patients with arousal and orgasmic sexual disorders. We found that women with sexual arousal and orgasmic disorders had significantly (p < 0.05) diminished clitoral peak systolic and end diastolic velocity responses compared to controls. Further research is needed to establish the diagnostic role of topical vasoactive agents in the hemodynamic evaluation of women with sexual dysfunction.


Sujet(s)
Alprostadil/pharmacologie , Clitoris , Dysfonctionnements sexuels psychogènes/imagerie diagnostique , Dysfonctionnements sexuels psychogènes/traitement médicamenteux , Échographie-doppler duplex , Vasodilatateurs/pharmacologie , Vasodilatateurs/usage thérapeutique , Administration par voie topique , Adulte , Alprostadil/administration et posologie , Clitoris/vascularisation , Clitoris/imagerie diagnostique , Clitoris/effets des médicaments et des substances chimiques , Femelle , Hémodynamique/physiologie , Humains , Vasodilatateurs/administration et posologie
19.
Reprod Biomed Online ; 6(1): 66-8, 2003.
Article de Anglais | MEDLINE | ID: mdl-12626145

RÉSUMÉ

This paper reports the birth of a healthy baby resulting from transfer of blastocysts that were cryopreserved using propanediol after spontaneous hatching. A young infertile couple underwent IVF treatment in the clinic. After several IVF attempts, two births resulted; the first one with fresh embryos in 1996 after three IVF cycles, and the second one in 1999 (after a new IVF cycle in 1998) with frozen blastocysts that had remained cryopreserved in 1.5 mol/l propanediol and 0.1 mol/l sucrose after spontaneous hatching. This report of a healthy baby following transfer of hatched blastocysts frozen in propanediol supports further exploration of this approach.


Sujet(s)
Blastocyste/métabolisme , Cryoconservation , Transfert d'embryon , Propylène glycols/métabolisme , Adulte , Femelle , Humains , Grossesse
20.
Hum Reprod ; 17(12): 3149-52, 2002 Dec.
Article de Anglais | MEDLINE | ID: mdl-12456615

RÉSUMÉ

BACKGROUND: Oocyte cryopreservation may have significant potential for assisted reproductive technology. However, to date, successful results have been limited. We report a preliminary series of IVF outcomes after fertilization of oocytes that were frozen in a low-sodium medium. METHODS: In this retrospective analysis, 12 patients (21-41 years old), who underwent IVF in a fertility clinic affiliated to the University of Buenos Aires, had oocytes cryopreserved in a modified phosphate buffered saline medium, in which sodium chloride was replaced by choline chloride. A slow-freezing, rapid-thawing protocol was used and oocytes were inseminated by ICSI. Outcome measures included oocyte survival, fertilization, implantation and pregnancy rates. RESULTS: Median oocyte survival was 63%. Median fertilization rate was 59%. Overall implantation rate was 25%. Six clinical pregnancies were achieved; two of these pregnancies went to term resulting in the birth of two babies. CONCLUSIONS: To the best of our knowledge, these are the first pregnancies and normal births using oocytes that were cryopreserved in a choline-based medium. The small sample size prevents us from concluding that freezing in a low-sodium medium is superior to using a conventional one.


Sujet(s)
Choline , Cryoconservation/méthodes , Ovocytes/physiologie , Issue de la grossesse , Injections intracytoplasmiques de spermatozoïdes , Adulte , Implantation embryonnaire , Transfert d'embryon , Femelle , Âge gestationnel , Humains , Nouveau-né , Mâle , Grossesse , Études rétrospectives
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE